How do you pay?

How to pay the least

Cash price

$900+ for 30 capsules

Pharmacies pay about this for Cobenfy; you’d pay more.

  1. Ask your pharmacy for Cobenfy’s cash price, and one or two other pharmacies too.
  2. Cobenfy’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Bristol Myers Squibb Patient Assistance Foundation (BMSPAF). Or call 1-800-736-0003.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameCobenfy
Authorized genericxanomeline and trospium chloride
Regular genericxanomeline and trospium chloride
What you’d pay
At least$900for 30 capsules; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Cobenfy?
The original
–
–

Brand nameThe maker’s card

COBENFY Co-Pay Assistance Program (COBENFY Cares)

Savings card from Bristol Myers Squibb

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on cobenfy.com 

Or call 1-877-262-3639.

In the maker’s words

“Eligible, commercially insured patients could pay as little as $0 per month for COBENFY™.”

From the maker’s offer on cobenfy.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Cobenfy itself, from the same company, sold without the brand name, and usually for less. For now Cobenfy is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, indicated for the treatment of schizophrenia in adults.

Source: the FDA label for Cobenfy (E.R. Squibb & Sons, L.L.C.), January 16, 2026. Full label on DailyMed 

Good to know